Former Hermès CEO Joins Macy’s Board As The Company Juggles Store Closures, Financial Scandal
Macy’s Inc. has appointed Robert Chavez, former Hermes Americas CEO, to the board. He faces challenges influencing strategy ...
Wayne biotech firm received $67.5 million investment to test gene therapy for heart disease
The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...
Scientists Are Racing to Develop a New Bird Flu Vaccine
A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.
Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)
In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...
FDA Urges Guillain-Barré Syndrome Warning On Labels Of RSV Vaccines Abrysvo And Arexvy
The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...
Global Severe Asthma Treatment Market Poised For Significant Growth To Reach USD 36.18 Billion By 2033: FMI Study
North America severe asthma market is set for growth, driven by high asthma prevalence, increased awareness, and advanced treatment options for severe cases. Ankush Nikam Future Market Insights, Inc.
Moderna stock on track for 20% weekly gain after US bird flu death
Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.
EurekAlert!1d
CCM Biosciences scientists report discovery of first-in-class longevity therapeutics
Compounds that enhance enzyme activity show promise for cellular rejuvenation and treating age-related diseases. However, ...